   
       
Non-Small Cell Lung Carcinoma
E1505 Principal Investigator: Larry Schlabach, MD
Co-Investigator: John McCravey, MD and Matt Graham, MD
Title: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (> 4 cm) - IIIA Non-Small Cell Lung Cancer (NSCLC) (IRB#: 07-087 )
NCT #: NCT00324805 Phase: Phase III
Purpose:This randomized phase III trial is studying chemotherapy and bevacizumab to see how well they work compared to chemotherapy alone in treating patients with stage IB, stage II, or stage IIIA non-small cell lung cancer that was removed by surgery.
Drugs possibly given:
Bevacizumab
Cisplatin
Docetaxel
Gemcitabine hydrochloride
Pemetrexed disodium
Vinorelbine tartrate
Please view complete information about this trial at: http://www.clinicaltrials.gov/ct2/show/NCT00324805?term=E1505&rank=1
|
